EMMPRIN-mediated MMP regulation in tumor and endothelial cells

Clinical and Experimental Metastasis

Volumn 19, Issue 8, 2002, Pages 697-702

  Caudroy, Stéphanie ^a   Polette, Myriam ^a   Nawrocki Raby, Béatrice ^a   Cao, Jian ^c   Toole, Bryan P ^b   Zucker, Stanley ^c   Birembaut, Philippe ^a  

^a HÔPITAL MAISON BLANCHE   (France)

^b TUFTS UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

EMMPRIN; MMPs; Neoangiogenesis; TIMPs; Tumor invasion

Indexed keywords

CD147 ANTIGEN; GELATINASE A; GELATINASE B; GLYCOPROTEIN; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME REGULATION; ENZYME SYNTHESIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

ANTIGENS, CD; ANTIGENS, CD147; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; DNA, COMPLEMENTARY; ENDOTHELIUM, VASCULAR; GELATIN; HUMANS; MATRIX METALLOPROTEINASES; MEMBRANE GLYCOPROTEINS; NEOPLASM INVASIVENESS; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036943814     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021350718226     Document Type: Article

References (30)

1. Ellerbroek SM, Stack MS. Membrane associated matrix metalloproteinases in metastasis. BioEssays 1999; 21: 940-9.
2. Curran S, Murray GI. Matrix metalloproteinases in tumor invasion and metastasis. J Pathol 1999; 189: 300-8.
3. Ura H, Bonfil RD, Reich R et al. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic invasive and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res 1989; 49: 4615-21.
4. Gilles C, Polette M, Piette J et al. Epithelial-to-mesenchymal transition in HPV-33-transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A. Int J Cancer 1994; 59: 661-6.
5. Polette M, Gilles C, de Bentzmann S et al. Association of fibroblastoid features with the invasive phenotype in human bronchial cancer cell lines. Clin Exp Metast 1998; 16: 105-12.
6. Polette M, Birembaut P. Matrix expression in breast cancers. Breast J 1996; 2: 209-20.
7. Stetler-Stevenson WG. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J Clin Invest 1999; 103: 1237-41.
8. Biswas C, Zhang Y, DeCastro R et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995; 55: 434-9.
9. Kataoka H, DeCastro R, Zucker S et al. Tumor cell-derived collagenase-stimularory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res 1993; 53: 3154-8.
10. Guo H, Zucker S, Gordon MK et al. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem 1997; 1: 24-7.
11. Ellis SM, Nabeshima K, Biswas C. Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor. Cancer Res 1989; 49: 3385-91.
12. Nabeshima K, Lane WS, Biswas C. Partial sequencing and characterization of the tumor cell-derived collagenase stimulatory factor. Arch Biochem Biophys 1991; 285: 90-6.
13. Muraoka K, Nabeshima K, Murayama T et al. Enhanced expression of tumor-cell-derived collagenase-stimulatory factor in urothelium carcinomas: Its usefull as a tumor marker for bladder cancers. Int J Cancer 1993; 55: 19-26.
14. Van den Oord JJ, Paemen L, Opdenakker G et al. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol 1997; 151: 665-70.
15. Caudroy S, Polette M, Tournier JM et al. Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions. J Histochem Cytochem 1999; 47: 1575-80.
16. Polette M, Gilles C, Marchand V et al. Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers. J Histochem Cytochem 1996; 45: 703-7.
17. Zucker S, Hymowitz M, Rollo EE et al. Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol 2001; 158: 1921-8.
18. Zucker S, Conner C, DiMassimo BI et al. Thrombin induces the activation of progelatinase A in vascular endothelial cells. J Biol Chem 1995; 270: 23730-8.
19. Zucker S, Mirza H, Conner CE et al. Vascular endothelial growth tissue factor and matrix metalloproteinases production in endothelial cells: Conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 1998, 75: 780-6.
20. Moutsiakis D, Mancuso P, Krutzsch H et al. Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma. Connective Tissue Res 1992; 28: 212-30.
21. Sun J, Hemler ME. Regulation of MMP-1 and MMP-2 production through CD147/Extracellular Matrix Metalloproteinase Inducer interactions. Cancer Res 2001; 61: 2276-81.
22. Strongin AY, Collier I, Bannikov G et al. Mechanism of cell surface activation of the 72 kD type IV collagenase: Isolation of the activate form of the membrane metalloproteinase. J Biol Chem 1995; 270: 5331-8.
23. Samehima T, Nabeshima K, Toole BP et al. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 2000; 157: 177-84.
24. Zucker S, Biswas C. Tumor collagenase stimulating factor: A paracrine stimulator of fibroblast production of matrix metalloproteinases in cancer. Bull Inst Pasteur 1994; 92: 284-90.
25. Bordador LC, Li XL, Toole B et al. Expression of EMMPRIN by oral squamous cell carcinomas. Int J Cancer 2000; 85: 347-52.
26. Guo H, Rongsong L, Zucker S et al. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res 2000; 60: 888-91.
27. Schnaper HW, Grant DS, Stetler-Stevenson WG et al. Type IV collagenase(s) and TIMPs modulate endothelial cell morphologenesis in vitro. J Cell Physiol 1993; 156: 235-46.
28. Fischer C, Gilbertson-Beadling S, Powers EA et al. Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 1994; 162: 499-510.
29. Hanemaaijer R, Koolwijk P, Le Clercq L et al. Regulation of matrix metalloproteinase expression in human vein microvascular endothelial cells. Biochem J 1993; 296: 803-9.
30. Taraboletti G, Garafola A, Belotti D et al. Inhibition of angiogenesis and murine hemangioma growth with batimastat, a synthetic inhibitor of metalloproteinases. J Natl Cancer Inst 1995; 87: 293-8.